CLINICAL_TRIALS
withdrawal
· 2024-06-03
Clinical Trial Update: HLA and it Relation With the Development of Proliferative Diabetic Retinopathy in Mexican Population [Phase 3]
Summary
A Phase 3 clinical trial investigating HLA and its relation to the development of proliferative diabetic retinopathy in Mexican patients with diabetes mellitus …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Asociación para Evitar la Ceguera en México | Conditions: Diabetes Mellitus Type 2, Proliferative Diabetic Retinopathy | Phase 3 | Status: WITHDRAWN